Total Payments
$3,835
2024 Payments
$2,643
Companies
8
Transactions
21
Medicare Patients
2,432
Medicare Billing
$326,538
Payment Breakdown by Category
Education$2,526 (65.9%)
Food & Beverage$687.60 (17.9%)
Travel$621.45 (16.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $2,526 | 2 | 65.9% |
| Food and Beverage | $687.60 | 17 | 17.9% |
| Travel and Lodging | $621.45 | 2 | 16.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $2,629 | 2 | $0 (2024) |
| Pulmonx Corporation | $830.32 | 4 | $0 (2023) |
| Ethicon Inc. | $188.08 | 8 | $0 (2023) |
| Covidien LP | $92.93 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $37.18 | 3 | $0 (2022) |
| Pharming Healthcare, Inc. | $26.00 | 1 | $0 (2022) |
| GENZYME CORPORATION | $17.29 | 1 | $0 (2023) |
| Tris Pharma Inc | $14.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,643 | 3 | INTUITIVE SURGICAL, INC. ($2,629) |
| 2023 | $86.34 | 4 | Ethicon Inc. ($52.74) |
| 2022 | $151.55 | 7 | Ethicon Inc. ($99.16) |
| 2021 | $228.74 | 3 | Pulmonx Corporation ($192.56) |
| 2020 | $347.78 | 2 | Pulmonx Corporation ($254.85) |
| 2019 | $366.60 | 1 | Pulmonx Corporation ($366.60) |
| 2017 | $10.79 | 1 | GlaxoSmithKline, LLC. ($10.79) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ADHD | ||||||
| 09/03/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $128.85 | General |
| Category: SURGERY | ||||||
| 05/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 12/13/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Immunology | ||||||
| 07/25/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: PULMONOLOGY | ||||||
| 05/19/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: Endo-Mechanical | ||||||
| 05/12/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Endo-Mechanical | ||||||
| 11/02/2022 | Pharming Healthcare, Inc. | — | Education | In-kind items and services | $26.00 | General |
| 09/03/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $42.29 | General |
| Category: Endo-Mechanical | ||||||
| 05/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Endo-Mechanical | ||||||
| 02/25/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Endo-Mechanical | ||||||
| 02/25/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Endo-Mechanical | ||||||
| 05/18/2021 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), PULMONX CHARTIS TABLET CONSOLE, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $192.56 | General |
| Category: PULMONOLOGY | ||||||
| 04/16/2021 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Endo-Mechanical | ||||||
| 04/16/2021 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Endo-Mechanical | ||||||
| 01/07/2020 | Covidien LP | LungGPS (Device) | Food and Beverage | In-kind items and services | $92.93 | General |
| Category: Interventional Lung Solutions | ||||||
| 01/03/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Travel and Lodging | Cash or cash equivalent | $254.85 | General |
| Category: Pulmonology | ||||||
| 11/14/2019 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Travel and Lodging | Cash or cash equivalent | $366.60 | General |
| Category: Pulmonology | ||||||
| 09/13/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 530 | 749 | $127,525 | $62,962 |
| 2022 | 13 | 555 | 796 | $138,341 | $69,021 |
| 2021 | 13 | 657 | 960 | $176,252 | $91,379 |
| 2020 | 13 | 690 | 1,011 | $191,644 | $103,176 |
Total Patients
2,432
Total Services
3,516
Medicare Billing
$326,538
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 47 | 112 | $35,840 | $17,779 | 49.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 117 | $17,433 | $10,597 | 60.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 97 | $18,527 | $8,498 | 45.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 57 | $16,587 | $7,189 | 43.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 80 | 119 | $12,376 | $6,944 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 82 | $10,988 | $5,038 | 45.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 46 | $9,108 | $3,979 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,952 | $1,900 | 48.1% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 12 | 12 | $1,020 | $326.04 | 32.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 31 | 31 | $620.00 | $282.72 | 45.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 29 | 29 | $609.00 | $218.96 | 36.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 31 | 31 | $465.00 | $210.18 | 45.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 53 | 142 | $45,440 | $23,829 | 52.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 118 | $17,582 | $9,231 | 52.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 63 | 64 | $18,624 | $8,925 | 47.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 91 | 146 | $15,184 | $7,846 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 49 | $9,359 | $4,395 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 69 | $9,246 | $4,191 | 45.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 43 | 44 | $8,712 | $4,091 | 47.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,187 | $2,490 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 19 | $5,073 | $2,254 | 44.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 25 | $2,100 | $986.92 | 47.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 35 | 35 | $700.00 | $319.27 | 45.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 35 | 35 | $525.00 | $237.50 | 45.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 29 | 29 | $609.00 | $225.52 | 37.0% |
About Dr. Daniel Murphy, MD
Dr. Daniel Murphy, MD is a Pulmonary Disease healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174734727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Murphy, MD has received a total of $3,835 in payments from pharmaceutical and medical device companies, with $2,643 received in 2024. These payments were reported across 21 transactions from 8 companies. The most common payment nature is "Education" ($2,526).
As a Medicare-enrolled provider, Murphy has provided services to 2,432 Medicare beneficiaries, totaling 3,516 services with total Medicare billing of $326,538. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Cincinnati, OH
- Active Since 05/25/2007
- Last Updated 09/15/2014
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1174734727
Products in Payments
- Da Vinci Surgical System (Device) $2,629
- Pulmonx Endobronchial Valve EBV (Device) $621.45
- ZEPHYR DELIVERY CATHETER (Device) $192.56
- Monarch Platform (Device) $188.08
- LungGPS (Device) $92.93
- TRELEGY ELLIPTA (Drug) $26.39
- DUPIXENT (Biological) $17.29
- CHARTIS CATHETER (Device) $16.31
- Dyanavel XR (Drug) $14.40
- BREO (Drug) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cincinnati
Shahrokh Javaheri, Md, MD
Pulmonary Disease — Payments: $431,707
Pulmonary Disease $431,707
Christopher Radchenko, M.d, M.D
Pulmonary Disease — Payments: $13,708
Pulmonary Disease $13,708
Dr. Karthikeyan Kanagarajan, M.d, M.D
Pulmonary Disease — Payments: $5,575
Pulmonary Disease $5,575
Dr. Christopher Schmitt, M.d, M.D
Pulmonary Disease — Payments: $4,968
Pulmonary Disease $4,968
Dr. Shahla Mallick, Md, MD
Pulmonary Disease — Payments: $4,853
Pulmonary Disease $4,853
Krishna Gannamraj, D.o, D.O
Pulmonary Disease — Payments: $3,039
Pulmonary Disease $3,039